Skip to main content
. Author manuscript; available in PMC: 2017 Oct 27.
Published in final edited form as: J Med Chem. 2017 Sep 18;60(18):7820–7834. doi: 10.1021/acs.jmedchem.7b00952

Table 3.

Interactions of Compounds 912 with Wild-type TTR and its V30M Variant

compound Kd,2 (μM) wild-type TTR V30M TTR binding modeb

%FF 1:1a %FF 2:1a %FF 1:1a %FF 2:1a
9 0.82 ± 0.01 30 ± 6 12 ± 2 62 ± 16 27 ± 10 NDc
10 0.47 ± 0.03 20 ± 3 3 ± 3 32 ± 9 8 ± 3 covalent
11 0.79 ± 0.03 26 ± 4 10 ± 3 54 ± 16 16 ± 5 forward/covalent
12 (tafamidis) 0.37 ± 0.01 22 ± 5 0 ± 6 5 ± 13 8 ± 7 forwardd
a

%FF, percent fibril formation.

b

”forward”: upper phenyl ring depicted in Chart 3 lies in the outer pocket of the T4-binding site, according to X-ray diffraction analysis (Figure 2);18 “covalent”: formation of a boronate ester with Ser117.

c

ND, not determined.

d

Ref. 21.